Kuano.ai raises £1m seed to de-risk and accelerate drug discovery using artificial intelligence and quantum computing The funding will go towards further development of its platform for generating better enzyme inhibitors London, 8 July 2021 – Kuano.ai, a software platform for rapid, cost effective quantum modelling of enzymes, has raised £1 million in seed funding … Continue reading Kuano secures £1 million Seed investment from investors including ACF Investors and o2h Ventures